Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer

FASEB Journal

Volumn 25, Issue 8, 2011, Pages 2615-2625

  Harris, Nicole C ^a,b   Paavonen, Karri ^a,c   Davydova, Natalia ^a,b   Roufail, Sally ^a,b   Sato, Teruhiko ^a,d   Zhang, You Fang ^a,b   Karnezis, Tara ^a,b   Stacker, Steven A ^a,b   Achen, Marc G ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF HELSINKI   (Finland)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Lymphangiogenesis; Metastasis; Neuropilin; VEGF D

Indexed keywords

VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CATALYSIS; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MALE; MAMMAL CELL; METASTASIS; METASTASIS INHIBITION; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PURIFICATION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; LYMPHANGIOGENESIS; MACROPHAGES; MICE; MICE, INBRED NOD; MICE, SCID; MUTANT PROTEINS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

ANIMALIA;

EID: 80051690785     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-179788     Document Type: Article

References (50)

1. Tammela, T., and Alitalo, K. (2010) Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140, 460-476
2. Shojaei, F., and Ferrara, N. (2007) Antiangiogenesis to treat cancer and intraocular neovascular disorders. Lab. Invest. 87, 227-230 (Pubitemid 46353946)
3. Tuttle, T. M. (2004) Technical advances in sentinel lymph node biopsy for breast cancer. Am. Surg. 70, 407-413
4. Shayan, R., Achen, M. G., and Stacker, S. A. (2006) Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 27, 1729-1738 (Pubitemid 44307827)
5. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844 (Pubitemid 23132159)
6. Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D. G., Orci, L., Alitalo, K., Christofori, G., and Pepper, M. S. (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20, 672- 682
7. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., and Detmar, M. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192-198 (Pubitemid 32148486)
8. Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S., Kubo, H., and Achen, M. G. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7, 186 -191
9. Karpanen, T., Egeblad, M., Karkkainen, M. J., Kubo, H., Ylä-Herttuala-Herttuala, S., Jäättelä, M., and Alitalo, K. (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61, 1786-1790 (Pubitemid 32691984)
10. Von Marschall, Z., Scholz, A., Stacker, S. A., Achen, M. G., Jackson, D. G., Alves, F., Schirner, M., Haberey, M., Thierauch, K. H., Wiedenmann, B., and Rosewicz, S. (2005) Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int. J. Oncol. 27, 669-679
11. Kopfstein, L., Veikkola, T., Djonov, V. G., Baeriswyl, V., Schomber, T., Strittmatter, K., Stacker, S. A., Achen, M. G., Alitalo, K., and Christofori, G. (2007) Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am. J. Pathol. 170, 1348-1361 (Pubitemid 47339341)
12. Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95, 1789 -1797
13. Achen, M. G., and Stacker, S. A. (2006) Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int. J. Cancer 119, 1755-1760 (Pubitemid 44356830)
14. Crawford, Y., and Ferrara, N. (2009) VEGF inhibition: insights from preclinical and clinical studies. Cell. Tiss. Res. 335, 261-269
15. Veikkola, T., Jussila, L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T. V., Kubo, H., Thurston, G., McDonald, D. M., Achen, M. G., Stacker, S. A., and Alitalo, K. (2001) Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 20, 1223-1231 (Pubitemid 32233963)
16. Byzova, T. V., Goldman, C. K., Jankau, J., Chen, J., Cabrera, G., Achen, M. G., Stacker, S. A., Carnevale, K. A., Siemionow, M., Deitcher, S. R., and DiCorleto, P. E. (2002) Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 99, 4434-4442 (Pubitemid 34627212)
17. Rissanen, T. T., Markkanen, J. E., Gruchala, M., Heikura, T., Puranen, A., Kettunen, M. I., Kholova, I., Kauppinen, R. A., Achen, M. G., Stacker, S. A., Alitalo, K., and Yla-Herttuala, S. (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92, 1098-1106 (Pubitemid 36665855)
18. Wise, L. M., Ueda, N., Dryden, N. H., Fleming, S. B., Caesar, C., Roufail, S., Achen, M. G., Stacker, S. A., and Mercer, A. A. (2003) Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens. J. Biol. Chem. 278, 38004-38014 (Pubitemid 37175331)
19. Bhardwaj, S., Roy, H., Gruchala, M., Viita, H., Kholova, I., Kokina, I., Achen, M. G., Stacker, S. A., Hedman, M., Alitalo, K., and Yla-Herttuala, S. (2003) Angiogenic responses of vascular endothelial growth factors in periadventitial tissue. Hum. Gene Ther. 14, 1451-1562
20. Rutanen, J., Rissanen, T. T., Markkanen, J. E., Gruchala, M., Silvennoinen, P., Kivela, A., Hedman, A., Hedman, M., Heikura, T., Orden, M. R., Stacker, S. A., Achen, M. G., Hartikainen, J., and Yla-Herttuala, S. (2004) Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109, 1029 -1035
21. Haiko, P., Makinen, T., Keskitalo, S., Taipale, J., Karkkainen, M. J., Baldwin, M. E., Stacker, S. A., Achen, M. G., and Alitalo, K. (2008) Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol. Cell. Biol. 28, 4843- 4850
22. Baldwin, M. E., Stacker, S. A., and Achen, M. G. (2002) Molecular control of lymphangiogenesis. Bioessays 24, 1030-1040 (Pubitemid 35326161)
23. Achen, M. G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A. F., Alitalo, K., and Stacker, S. A. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. U. S. A. 95, 548-553 (Pubitemid 28083780)
24. Rutanen, J., Leppanen, P., Tuomisto, T. T., Rissanen, T. T., Hiltunen, M. O., Vajanto, I., Niemi, M., Hakkinen, T., Karkola, K., Stacker, S. A., Achen, M. G., Alitalo, K., and Yla-Herttuala, S. (2003) Vascular endothelial growth factor-D expression in human atherosclerotic lesions. Cardiovasc. Res. 59, 971-979 (Pubitemid 38366253)
25. Hong, Y. K., Lange-Asschenfeldt, B., Velasco, P., Hirakawa, S., Kunstfeld, R., Brown, L. F., Bohlen, P., Senger, D. R., and Detmar, M. (2004) VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J. 18, 1111-1113 (Pubitemid 39561540)
26. Goldman, J., Rutkowski, J. M., Shields, J. D., Pasquier, M. C., Cui, Y., Schmokel, H. G., Willey, S., Hicklin, D. J., Pytowski, B., and Swartz, M. A. (2007) Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J. 21, 1003-1012 (Pubitemid 46495690)
27. Wirzenius, M., Tammela, T., Uutela, M., He, Y., Odorisio, T., Zambruno, G., Nagy, J. A., Dvorak, H. F., Ylä-Herttuala, S., Shibuya, M., and Alitalo, K. (2007) Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J. Exp. Med. 204, 1431-1440 (Pubitemid 46919880)
28. Laakkonen, P., Waltari, M., Holopainen, T., Takahashi, T., Pytowski, B., Steiner, P., Hicklin, D., Persaud, K., Tonra, J. R., Witte, L., and Alitalo, K. (2007) Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res. 67, 593-599 (Pubitemid 46192197)
29. Tammela, T., Zarkada, G., Wallgard, E., Murtomaki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellstrom, M., Schomber, T., Peltonen, R., Freitas, C., Duarte, A., Isoniemi, H., Laakkonen, P., Christofori, G., Ylä-Herttuala, S., Shibuya, M., Pytowski, B., Eichmann, A., Betsholtz, C., and Alitalo, K. (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454, 656-660
30. Nilsson, I., Bahram, F., Li, X., Gualandi, L., Koch, S., Jarvius, M., Soderberg, O., Anisimov, A., Kholova, I., Pytowski, B., Baldwin, M., Ylä-Herttuala, S., Alitalo, K., Kreuger, J., and Claesson-Welsh, L. (2010) VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J. 29, 1377-1388
31. McColl, B. K., Paavonen, K., Karnezis, T., Harris, N. C., Davydova, N., Rothacker, J., Nice, E. C., Harder, K. W., Roufail, S., Hibbs, M. L., Rogers, P. A., Alitalo, K., Stacker, S. A., and Achen, M. G. (2007) Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J. 21, 1088-1098 (Pubitemid 46495698)
32. Stacker, S. A., Stenvers, K., Caesar, C., Vitali, A., Domagala, T., Nice, E., Roufail, S., Simpson, R. J., Moritz, R., Karpanen, T., Alitalo, K., and Achen, M. G. (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J. Biol. Chem. 274, 32127-32136
33. Baldwin, M. E., Roufail, S., Halford, M. M., Alitalo, K., Stacker, S. A., and Achen, M. G. (2001) Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis. J. Biol. Chem. 276, 44307-44314
34. Karpanen, T., Heckman, C. A., Keskitalo, S., Jeltsch, M., Ollila, H., Neufeld, G., Tamagnone, L., and Alitalo, K. (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20, 1462-1472 (Pubitemid 44943854)
35. Banerji, S., Ni, J., Wang, S. X., Clasper, S., Su, J., Tammi, R., Jones, M., and Jackson, D. G. (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789-801 (Pubitemid 29234556)
36. Gordon, E. J., Gale, N. W., and Harvey, N. L. (2008) Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels. Dev. Dyn. 237, 1901-1909 (Pubitemid 351962466)
37. Breiteneder-Geleff, S., Matsui, K., Soleiman, A., Meraner, P., Poczewski, H., Kalt, R., Schaffner, G., and Kerjaschki, D. (1997) Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am. J. Pathol. 151, 1141-1152 (Pubitemid 27424324)
38. Erber, R., Thurnher, A., Katsen, A. D., Groth, G., Kerger, H., Hammes, H. P., Menger, M. D., Ullrich, A., and Vajkoczy, P. (2004) Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J. 18, 338-340
39. Ozerdem, U., Grako, K. A., Dahlin-Huppe, K., Monosov, E., and Stallcup, W. B. (2001) NG2 proteoglycan is expressed exclu- sively by mural cells during vascular morphogenesis. Dev. Dyn. 222, 218-227 (Pubitemid 32937594)
40. Schoppmann, S. F., Birner, P., Stockl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., and Kerjaschki, D. (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161, 947-956 (Pubitemid 34988382)
41. Austyn, J. M., and Gordon, S. (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815 (Pubitemid 12237981)
42. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745 (Pubitemid 28155313)
43. Siegfried, G., Basak, A., Cromlish, J. A., Benjannet, S., Marcinkiewicz, J., Chretien, M., Seidah, N. G., and Khatib, A. M. (2003) The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J. Clin. Invest. 111, 1723-1732 (Pubitemid 38057753)
44. Xu, Y., Yuan, L., Mak, J., Pardanaud, L., Caunt, M., Kasman, I., Larrivee, B., Del Toro, R., Suchting, S., Medvinsky, A., Silva, J., Yang, J., Thomas, J. L., Koch, A. W., Alitalo, K., Eichmann, A., and Bagri, A. (2010) Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J. Cell Biol. 188, 115-130
45. Leppanen, V. M., Jeltsch, M., Anisimov, A., Tvorogov, D., Aho, K., Kalkkinen, N., Toivanen, P., Ylä-Herttuala, S., Ballmer-Hofer, K., and Alitalo, K. (2011) Structural determinants of vascular endothelial growth factor-D receptor binding and specificity. Blood 117, 1507-1515
46. Skobe, M., Hamberg, L. M., Hawighorst, T., Schirner, M., Wolf, G. L., Alitalo, K., and Detmar, M. (2001) Concurrent induction of lymphangiogenesis, angiogenesis and macrophage recruitment by vascular endothelial growth factor C in melanoma. Am. J. Pathol. 159, 893-903 (Pubitemid 32847180)
47. Achen, M. G., and Stacker, S. A. (2008) Molecular control of lymphatic metastasis. Ann. N. Y. Acad. Sci. 1131, 225-234 (Pubitemid 351758517)
48. Bassi, D. E., Fu, J., Lopez de Cicco, R., and Klein-Szanto, A. J. (2005) Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol. Carcinog. 44, 151-161 (Pubitemid 41552748)
49. Bassi, D. E., Zhang, J., Cenna, J., Litwin, S., Cukierman, E., and Klein-Szanto, A. J. (2010) Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis. Neoplasia 12, 516-526
50. Khatib, A. M., Siegfried, G., Prat, A., Luis, J., Chretien, M., Metrakos, P., and Seidah, N. G. (2001) Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulinlike growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J. Biol. Chem. 276, 30686-30693